These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28504861)

  • 1. The efficacy of benzodiazepines as acute anxiolytics in children: A meta-analysis.
    Kuang H; Johnson JA; Mulqueen JM; Bloch MH
    Depress Anxiety; 2017 Oct; 34(10):888-896. PubMed ID: 28504861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis.
    Takeshima M; Otsubo T; Funada D; Murakami M; Usami T; Maeda Y; Yamamoto T; Matsumoto T; Shimane T; Aoki Y; Otowa T; Tani M; Yamanaka G; Sakai Y; Murao T; Inada K; Yamada H; Kikuchi T; Sasaki T; Watanabe N; Mishima K; Takaesu Y
    Psychiatry Clin Neurosci; 2021 Apr; 75(4):119-127. PubMed ID: 33448517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin for preoperative and postoperative anxiety in adults.
    Madsen BK; Zetner D; Møller AM; Rosenberg J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009861. PubMed ID: 33319916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials.
    Rossano F; Caiazza C; Zotti N; Viacava L; Irano A; Solini N; Pistone L; Pezone R; Cilmi F; Ricci C; De Prisco M; Iasevoli F; Kishi T; Solmi M; de Bartolomeis A; Fornaro M
    Eur Neuropsychopharmacol; 2023 Nov; 76():23-51. PubMed ID: 37544075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: Systematic review and meta-analysis.
    Gale C; Glue P; Guaiana G; Coverdale J; McMurdo M; Wilkinson S
    J Psychopharmacol; 2019 May; 33(5):543-547. PubMed ID: 30676225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic predictors of benzodiazepine response trajectory in anxiety disorders: a Bayesian hierarchical modeling meta-analysis.
    Stimpfl JN; Mills JA; Strawn JR
    CNS Spectr; 2023 Feb; 28(1):53-60. PubMed ID: 34593077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacologic treatment of children and adolescents with anxiety disorders.
    Strawn JR; Sakolsky DJ; Rynn MA
    Child Adolesc Psychiatr Clin N Am; 2012 Jul; 21(3):527-39. PubMed ID: 22800992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepines in the treatment of anxiety.
    Rickels K
    Am J Psychother; 1982 Jul; 36(3):358-70. PubMed ID: 6128929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants plus benzodiazepines for adults with major depression.
    Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anxiety; pharmacological bases of treatment].
    de Andrés Rodríguez-Trelles F
    An R Acad Nac Med (Madr); 1981; 98(1):69-116. PubMed ID: 6115590
    [No Abstract]   [Full Text] [Related]  

  • 12. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials.
    Martin JL; Sainz-Pardo M; Furukawa TA; Martín-Sánchez E; Seoane T; Galán C
    J Psychopharmacol; 2007 Sep; 21(7):774-82. PubMed ID: 17881433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azapirones for generalized anxiety disorder.
    Chessick CA; Allen MH; Thase M; Batista Miralha da Cunha AB; Kapczinski FF; de Lima MS; dos Santos Souza JJ
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006115. PubMed ID: 16856115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
    Nicotra CM; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis.
    Bontempo A; Panza KE; Bloch MH
    J Clin Psychiatry; 2012 Apr; 73(4):533-7. PubMed ID: 22579153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute treatment of anxiety and depression.
    Swinson RP
    Psychiatr J Univ Ott; 1989 Jun; 14(2):375-8; discussion 379-80. PubMed ID: 2569748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies.
    Peng TR; Yang LJ; Wu TW; Chao YC
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33019585
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug treatment of anxiety disorders].
    Corfdir C; Pelissolo A
    Rev Prat; 2019 Nov; 69(9):981-984. PubMed ID: 32237616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of anxiolytics in children.
    Siméon JG
    Encephale; 1993; 19(2):71-4. PubMed ID: 7903927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term versus long-term benzodiazepine therapy.
    Lader M
    Curr Med Res Opin; 1984; 8 Suppl 4():120-6. PubMed ID: 6144459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.